NME1 and cancer: Our previous studies have shown that Sp1 is induced in the early period of cancer formation5, implying that Nm23-H1, hnRNPA2/B1, and Sp1 could all be considered early biomarkers of lung cancer and should be evaluated for lung cancer prognosis.